Aaboe K, Krarup T, Madsbad S, Holst JJ (2008) <br />GLP-1: physiological effects and potential therapeutic applications<br /><i>Diabetes Obes Metab</i> <b>10</b>: 994<br /><br />Holst JJ, Deacon CF, Vilsboll T, Krarup T, Madsbad S (2008) <br />Glucagon-like peptide-1, glucose homeostasis and diabetes<br /><i>Trends Mol Med</i> <b>14</b>: 161<br /><br />Madsbad S, Krarup T, Deacon CF, Holst JJ (2008) <br />Glucagon-like peptide receptor agonists and dipeptidyl peptidase-4 inhibitors in the treatment of diabetes: a review of clinical trials<br /><i>Curr Opin Clin Nutr Metab Care</i> <b>11</b>: 491<br /><br />Ryskjaer J, Deacon CF, Carr RD, Krarup T, Madsbad S, Holst J, Vilsboll T (2006) <br />Plasma dipeptidyl peptidase-IV activity in patients with type-2 diabetes mellitus correlates positively with HbAlc levels, but is not acutely affected by food intake<br /><i>European Journal of Endocrinology</i> <b>155</b>: 485<br /><br />